HUTCHMED (China) Ltd (HCM) stock
HCMNasdaqPharmaceutical PreparationsAlso trades as HMDCF
$14.40−0.33 (-2.24%)
Close on Nov 17, 2026Market cap $2.51BP/E 5.5Yield –
HUTCHMED (China) price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
HUTCHMED (China)'s price to sales ratio was 4.8× on Nov 11, 2026, against 4.0× a year earlier. Over the last 5 years it ranged from 2.8× to 21.5×, with a median of 4.4×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 4.8× | +1.1 |
| 2025 | Dec 31, 2025 | 3.7× | +0.7 |
| 2024 | Dec 31, 2024 | 3.0× | −4.2 |
| 2023 | Dec 29, 2023 | 7.2× | +0.6 |
| 2022 | Dec 30, 2022 | 6.6× | −14.9 |
| 2021 | Dec 31, 2021 | 21.5× | +0.7 |
| 2020 | Dec 31, 2020 | 20.8× | +4.5 |
| 2019 | Dec 31, 2019 | 16.3× | +4.5 |
| 2018 | Dec 31, 2018 | 11.8× | −10.1 |
| 2017 | Dec 29, 2017 | 21.9× | +13.6 |
| 2016 | Dec 30, 2016 | 8.3× | – |
See a number that looks wrong?